Dr. Raajit K. Rampal

Dr. Raajit K. Rampal, MD, PhD, is a hematologist-oncologist specializing in the treatment of myeloproliferative neoplasms (MPN) and leukemia. He is dedicated to providing individualized care that takes into account the unique needs of each patient and his or her family. Dr. Rampal combines a deep commitment to clinical excellence with an active research program focused on advancing the understanding and treatment of these complex blood cancers.

As a researcher, Dr. Rampal works to uncover the genetic events that drive the development and progression of leukemia and MPNs, with the goal of translating these insights into new targeted therapies. He is actively engaged in developing and running novel clinical trials that evaluate molecularly targeted agents for patients with these diseases. His work bridges the laboratory and the clinic, connecting basic scientific discovery to meaningful advances in patient care.

Through his dual role as a clinician and investigator, Dr. Rampal remains steadfast in his commitment to improving outcomes for people affected by MPNs and leukemia. His patient-centered approach, combined with his dedication to scientific innovation, reflects a broad commitment to advancing the field and offering patients access to emerging therapeutic options.